Relationship Between Plasma Pentraxin 3 Concentration and Platelet Indices in Patients With Stable Coronary Artery Disease

scientific article

Relationship Between Plasma Pentraxin 3 Concentration and Platelet Indices in Patients With Stable Coronary Artery Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/0003319717732929
P698PubMed publication ID28946774

P50authorAndrzej LekstonQ68692655
Mariusz GąsiorQ68692886
Aleksander DanikiewiczQ104071777
Janusz SzkodzińskiQ114424337
Ilona Korzonek-SzlachetaQ114424342
Bartosz HudzikQ56489121
Barbara Zubelewicz-SzkodzińskaQ64295906
P2093author name stringJustyna Nowak
P2860cites workThe inflammatory protein Pentraxin 3 in cardiovascular diseaseQ26738957
Are platelet volume indices of clinical use? A multidisciplinary reviewQ33400229
Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerabilityQ33768947
Production of the long pentraxin PTX3 in advanced atherosclerotic plaquesQ34128059
Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul StudyQ34150807
Pentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY StudiesQ34154838
Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cellsQ34180480
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarctionQ34357988
Inflammation and atherosclerosis: role of C-reactive protein in risk assessmentQ35721270
Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregationQ36869842
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis.Q37127450
Pentraxins, humoral innate immunity and tissue injuryQ37200012
Methods for the measurement of platelet functionQ37376459
The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.Q37775325
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysisQ38271064
Biological actions of pentraxinsQ38472979
Pentraxin 3 promotes oxLDL uptake and inhibits cholesterol efflux from macrophage-derived foam cellsQ39011075
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric BandingQ40246833
Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarctionQ48395268
Regulation of leukocyte recruitment by the long pentraxin PTX3.Q51774594
Mean platelet volume-to-lymphocyte ratio: a novel marker of poor short- and long-term prognosis in patients with diabetes mellitus and acute myocardial infarction.Q52871727
Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions.Q53502969
Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction.Q53708193
Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina PectorisQ56942761
Pentraxin 3　– A Link Between Obesity, Inflammation and Vascular Disease? –Q58420640
P433issue3
P304page(s)264-269
P577publication date2017-01-01
P1433published inAngiologyQ4763277
P1476titleRelationship Between Plasma Pentraxin 3 Concentration and Platelet Indices in Patients With Stable Coronary Artery Disease
P478volume69

Reverse relations

cites work (P2860)
Q48238553Association Between Platelet Indices and Inflammation in Patients With Stable Coronary Artery Disease.
Q91896596Cardiovascular Risk Factors and Haematological Indexes of Inflammation in Paralympic Athletes with Different Motor Impairments

Search more.